Developing and Validating an LDT for IDH1/2 Mutations and MGMT Methylation

被引：0
|
作者：
Hudzik, C. [1 ]
Yan, L. [1 ]
机构：
[1] EpigenDx Inc, Hopkinton, MA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2024年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
G041
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [31] The association between IDH1 mutation and MGMT promoter methylation in Indonesian glioma patients
    Hudiana, Dina
    Malueka, Rusdy
    Dananjoyo, Kusumo
    Asmedi, Ahmad
    Dwianingsih, Ery Kus
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [32] XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
    Le, Nguyen Quoc Khanh
    Do, Duyen Thi
    Chiu, Fang-Ying
    Yapp, Edward Kien Yee
    Yeh, Hui-Yuan
    Chen, Cheng-Yu
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 13
  • [33] Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
    Wick, Wolfgang
    Meisner, Christoph
    Hentschel, Bettina
    Platten, Michael
    Schilling, Alissa
    Wiestler, Benedikt
    Sabel, Michael C.
    Koeppen, Susanne
    Ketter, Ralf
    Weiler, Markus
    Tabatabai, Ghazaleh
    von Deimling, Andreas
    Gramatzki, Dorothee
    Westphal, Manfred
    Schackert, Gabriele
    Loeffler, Markus
    Simon, Matthias
    Reifenberger, Guido
    Weller, Michael
    NEUROLOGY, 2013, 81 (17) : 1515 - 1522
  • [34] Targeting IDH1/IDH2 mutations in gliomas
    de la Fuente, Macarena I.
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (06) : 787 - 793
  • [35] IDH1 and IDH2 Mutations in Gliomas REPLY
    Reitman, Zachary
    Yan, Hai
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2249 - 2249
  • [36] Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status
    Myung, Jae Kyung
    Cho, Hwa Jin
    Kim, Hanna
    Park, Chul-Kee
    Lee, Se Hoon
    Choi, Seung Hong
    Park, Peom
    Yoon, Jung Min
    Park, Sung-Hye
    TRANSLATIONAL ONCOLOGY, 2014, 7 (06): : 712 - 719
  • [37] IDH1 reactivity and mosaic IDH1 or IDH2 somatic mutations in solitary enchondroma and enchondromatosis
    Saiji, E.
    Biderbost, C. Cerato
    Berczy, M.
    Rougemont, A. -L.
    VIRCHOWS ARCHIV, 2015, 467 : S167 - S167
  • [38] OBSERVATION OF THE FREQUENCY OF MGMT METHYLATION, BRAF V600E MUTATION AND IDH1/2 MUTATIONS IN A GREEK BRAIN TUMOR COHORT
    Grossi, I.
    Rigakos, G.
    Lampropoulos, S.
    Stavridi, F.
    Tsoulos, N.
    Nasioulas, G.
    Papadopoulou, E.
    Razis, E.
    NEURO-ONCOLOGY, 2012, 14 : 41 - 41
  • [39] IDH1 MUTATIONS, EGFR GENE AMPLIFICATION AND MGMT GENE PROMOTER METHYLATION IN GLIOSARCOMAS: SERIES OF 31 CASES WITH CLINCOPATHOLOGICAL FEATURES
    Epari, Sridhar
    Ahmed, Sharique
    Gurav, Mamta
    Raikar, Swati
    Moiyadi, Aliasgar
    Shetty, Prakash
    Gupta, Tejpal
    Jalali, Rakesh
    NEURO-ONCOLOGY, 2013, 15 : 157 - 157
  • [40] IDH1 Mutations in Gliomas
    Ohgaki, Hiroko
    Watanabe, Takuya
    Nobusawa, Sumihito
    Kleihues, Paul
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 559 - 559
12345